Skip to main content
. 2018 Sep 8;7(10):670–677. doi: 10.1002/psp4.12316

Figure 1.

Figure 1

Nonlinear pharmacokinetics for efalizumab, mavrilumab, and romosozumab. Note that for all three drugs, as the concentration drops below the critical concentration (C crit), the elimination rate suddenly increases.